MacroGenics Inc (MGNX)

MacroGenics Inc (MGNX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $218M; returns 1 day -38.0%, 1 week -30.8%, 1 year +23.0%.

MacroGenics Inc. (MGNX) is a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative antibody-based therapeutics for the treatment of cancer.

Groups MGNX belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Antibody Therapeutics
• Cancer Therapeutics
• Antibody-Drug Conjugates
• Bispecific Antibodies
• Clinical Stage
• Biopharmaceutical
• Healthcare
• Strategic Partnerships
• Contract Development and Manufacturing Organizations (CDMO)

MGNX financial model: income statement, cash flow and balance sheet